A package of Beyfortus, in an undated file photograph. Fred Tanneau/AFP via Getty ImagesAn antibody that protects against respiratory syncytial virus (RSV) works well for one year but possibly not beyond, according to newly published research.Nirsevimab, the antibody, “may not be effective after 12 months of administration,” Japanese researchers reported in the study, which was published on Nov. 6 by the Journal of Infection.
Antibody Against RSV Prevents Cases for 1 Year: Study
Date:
More like thisRelated
Japan Condemns Chinese Diplomats Threats Over Taiwan
Japan’s prime minister said a Chinese military attack against...
North Korea Vows More Offensive Action After US Aircraft Carrier Visits South Korea
North Korean leader Kim Jong Un leads a party...
UK to Help NATO Ally Belgium After Series of Drone Incursions
The logo of Brussels international airport outside the terminal...
China Grants Exemptions to Nexperia Chip Export Restrictions for Civilian Use
The logo of Nexperia in Hamburg, Germany, on June...